Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.
Sec. Cardiovascular Epidemiology and Prevention
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1414792
This article is part of the Research Topic Nutrigenetics of Cardiovascular Health: Understanding Individual Responses to Dietary Interventions View all articles

Association of serum iron with all-cause mortality and cardiovascular mortality in the cardiovascular patients: a retrospective cohort study based on the NHANES 1999-2018

Provisionally accepted
Jing Lu Jing Lu Zhen Ma Zhen Ma *Xiaoxue Zhang Xiaoxue Zhang *Wenhao Zhong Wenhao Zhong Yunzeng Zou Yunzeng Zou *Jie Yuan Jie Yuan *
  • Shanghai Institute of Cardiovascular Diseases,Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China

The final, formatted version of the article will be published soon.

    Background: Cardiovascular disease (CVD) is one of the leading global causes of death, and serum iron (SI) levels may be associated with the mortality of CVD. However, there is still a knowledge gap regarding the relationship between SI and mortality in the CVD population.Methods: An analysis was conducted utilizing data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018.In our study, SI was used as the independent variable, and the mortality of the CVD patients was considered as the outcome. Kaplan-Meier curves, multivariable Cox proportional hazards model, and restricted cubic spline were employed to examine the association between SI and all-cause mortality and cardiovascular mortality in CVD patients. Subgroup analysis was also carried out based on age, sex, weight, hypertension, Type 2 diabetes mellitus, and smoking status.Results: A retrospective cohort study design was utilized, incorporating data from 1,903 CVD patients with an average age of 64.29 years.Kaplan-Meier survival analysis demonstrated significant differences in all-cause mortality and cardiovascular mortality among the CVD patients based on quartiles of SI. Following multivariable adjustment, lower SI was associated with an increased risk of all-cause and cardiovascular mortality in CVD patients. The highest quartile of SI exhibited a 43% reduction in all-cause mortality (HR=0.57, 95% CI: 0.45-0.72) and a 74% reduction in cardiovascular mortality (HR=0.26, 95% CI: 0.16-0.43) when compared to the lowest quartile. Restricted cubic spline showed a nonlinear relationship between SI and all-cause mortality and a linear relationship between SI and cardiovascular mortality. Additionally, the inverse relationship between SI levels and outcomes in the CVD patients remained consistent in subgroup analysis.Higher SI is associated with a decreased risk of all-cause and cardiovascular mortality in CVD patients. Our results emphasize the importance of iron supplementation for this particular group.

    Keywords: cardiovascular disease, serum iron, national Health and Nutrition Examination Survey (NHANES), All-cause mortality, Cardiovascular mortality

    Received: 11 Apr 2024; Accepted: 22 Nov 2024.

    Copyright: © 2024 Lu, Ma, Zhang, Zhong, Zou and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Zhen Ma, Shanghai Institute of Cardiovascular Diseases,Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China
    Xiaoxue Zhang, Shanghai Institute of Cardiovascular Diseases,Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China
    Yunzeng Zou, Shanghai Institute of Cardiovascular Diseases,Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China
    Jie Yuan, Shanghai Institute of Cardiovascular Diseases,Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.